Intrexon

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Intrexon Corporation
Traded asNYSEXON
Russell 2000 Component
IndustryBiotechnology
FoundedMay 21, 1998; 21 years ago (1998-05-21)
Websitedna.com

Intrexon Corporation (NYSE: XON) is an American biotechnology company, and its chairman and CEO is Randal J. Kirk.

Intrexon was founded in 1998, and is headquartered in Germantown, Maryland.[1][2] With a suite of proprietary and complementary technologies, Intrexon applies engineering to biological systems to enable DNA-based control over the function and output of living cells.[3]

History[edit]

In 2015, Intrexon purchased Oxitec, a maker of gene drive technology for $160 million.[4]

References[edit]

  1. ^ "Intrexon Corporation: Private Company Information". Bloomberg. Retrieved 2017-06-26.
  2. ^ "Intrexon Corp (XON) Company Profile". Reuters.com. Retrieved 2017-06-26.
  3. ^ "FAQ | Intrexon". Intrexon InvestorRoom. Retrieved 2018-03-28.
  4. ^ Nickel, Rod (15 September 2015). "Market turbulence or not, North American investors plow into farm tech". Reuters. Retrieved 9 October 2015.

External links[edit]

Official website